Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?

Autor: Huibers M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Abla O; Division of Hematology and Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, Canada., Andrés M; Department of Pediatric Hematology and Oncology, University Hospital La Fe of Valencia, Valencia, Spain., Balagué O; Hematopathology section, Pathology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain., Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Carraro E; Maternal and Child Health Department, Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padova, Padova, Italy., Chiang A; Department of Paediatrics & Adolescent Medicine, The University of Hong Kong, Hong Kong., Csóka M; Pediatric Clinic (Tűzoltó Street Department), Semmelweis University, Budapest, Hungary., David BA; Department of Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital Liège, Liège, Belgium., de Ville de Goyet M; Department of Pediatric Hematology and Oncology, Cliniques universitaires Saint-Luc, UC Louvain, Brussels, Belgium., Gilad G; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petah Tikva, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Hori D; Department of Hematology and Oncology for children and adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan., Kotecha RS; Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Perth, Australia.; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.; Curtin Medical School, Curtin University, Perth, Australia., Kabickova E; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic., Klapper W; Hematopathology Section, Department of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany., Miakova N; Department of Pediatric Hematology and Oncology, Federal Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Minard-Colin V; Department of Pediatric and Adolescent Oncology, Gustave-Roussy Cancer Campus, Paris-Sacaly University, Villejuif, France., Nakazawa A; Department of Clinical Research, Saitama Children's Medical Center, Saitama, Japan., Pillon M; Hematopathology section, Pathology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain., Rigaud C; Department of Pediatric and Adolescent Oncology, Gustave-Roussy Cancer Campus, Paris-Sacaly University, Villejuif, France., Salaverria I; Department of Pathology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Tölle I; Pediatric Hematology and Oncology and NHL-BFM Study Center, University Hospital Münster, Münster, Germany., Verdú-Amorós J; Department of Pediatric Hematology and Oncology, University Hospital La Fe of Valencia, Valencia, Spain.; Department of Pediatric Hematology and Oncology, Hospital Clínico Universitario, Biomedical Research Institute, INCLIVA, Valencia, Spain., von Mersi H; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria., Wössmann W; Pediatric Hematology and Oncology and NHL-BFM Study Center, Medical Center Hamburg-Eppendorf, Hamburg, Germany., Burkhardt B; Pediatric Hematology and Oncology and NHL-BFM Study Center, University Hospital Münster, Münster, Germany., Attarbaschi A; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.
Jazyk: angličtina
Zdroj: Blood advances [Blood Adv] 2024 Mar 26; Vol. 8 (6), pp. 1509-1514.
DOI: 10.1182/bloodadvances.2023012109
Databáze: MEDLINE